JP Morgan Maintains Neutral on Teladoc Health, Raises Price Target to $10
Benzinga Newsdesk 12 hours ago
Analyst RatingsNewsPrice Target
JP Morgan analyst Lisa Gill maintains Teladoc Health (NYSE:TDOC) with a Neutral and raises the price target from $8 to $10.
JP Morgan analyst Lisa Gill maintains Teladoc Health (NYSE:TDOC) with a Neutral and raises the price target from $8 to $10.